Why Novo Nordisk Stock Tumbled by Nearly 3% on Tuesday

High-flying healthcare stock Novo Nordisk (NVO -2.58%) lost a bit of altitude on Tuesday, following its latest news from the laboratory. A clinical trial wasn't quite as successful as hoped, and investors expressed their displeasure by trading out of the Danish company's shares. At the end of the day, the stock had lost nearly 3% of its value, comparing unfavorably to the 1% decline of the benchmark S&P 500 index.A clinical trial fell short of expectationsNovo Nordisk is busy developing semaglutide, sold un ...